[1]
“Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the ‘3E initiative’”, Reumatismo, vol. 62, no. 1, pp. 34–45, Mar. 2010, doi: 10.4081/reumatismo.2010.34.